BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND FANCC, ENSG00000158169, 2176, RP11-80I15_2, FAC, FA3, FACC, FLJ14675
111357 results:

  • 1. A population-based analysis of the management of symptoms of depression among patients with stage IV non-small cell lung cancer (NSCLC) in Ontario, Canada.
    Tan VS; Tjong MC; Chan WC; Yan M; Delibasic V; Darling G; Davis LE; Doherty M; Hallet J; Kidane B; Mahar A; Mittmann N; Parmar A; Tan H; Wright FC; Coburn NG; Louie AV
    Support Care Cancer; 2024 May; 32(6):381. PubMed ID: 38787434
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Sentinel Lymph Node Mapping in lung cancer: A Pilot Study for the Detection of Micrometastases in Stage I Non-Small Cell lung cancer.
    Romano G; Zirafa CC; Calabrò F; Alì G; Manca G; De Liperi A; Proietti A; Manfredini B; Di Stefano I; Marciano A; Davini F; Volterrani D; Melfi F
    Tomography; 2024 May; 10(5):761-772. PubMed ID: 38787018
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Effects of sEH inhibition on the eicosanoid and cytokine storms in SARS-CoV-2-infected mice.
    Edin ML; Gruzdev A; Graves JP; Lih FB; Morisseau C; Ward JM; Hammock BD; Bosio CM; Zeldin DC
    FASEB J; 2024 May; 38(10):e23692. PubMed ID: 38786655
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The Role of TLR-2 in Lethal COVID-19 Disease Involving Medullary and Resident lung Megakaryocyte Up-Regulation in the Microthrombosis Mechanism.
    Pannone G; Pedicillo MC; De Stefano IS; Angelillis F; Barile R; Pannone C; Villani G; Miele F; Municinò M; Ronchi A; Serviddio G; Zito Marino F; Franco R; Colangelo T; Zamparese R
    Cells; 2024 May; 13(10):. PubMed ID: 38786077
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Upregulation of mRNA Expression of ADGRD1/GPR133 and ADGRG7/GPR128 in SARS-CoV-2-Infected lung Adenocarcinoma Calu-3 Cells.
    Žáčková S; Pávová M; Trylčová J; Chalupová J; Priss A; Lukšan O; Weber J
    Cells; 2024 May; 13(10):. PubMed ID: 38786015
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Patient and Family Financial Burden in cancer: A Focus on Differences across Four Provinces, and Reduced Spending Including Decisions to Forego Care in Canada.
    Longo CJ; Maity T; Fitch MI; Young JT
    Curr Oncol; 2024 May; 31(5):2713-2726. PubMed ID: 38785487
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Sublobar Resection of Non-Small-Cell lung cancer: Wedge Resection vs. Segmentectomy.
    Yu KR; Julliard WA
    Curr Oncol; 2024 Apr; 31(5):2497-2507. PubMed ID: 38785468
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Transthoracic CT-guided core biopsy of high pulmonary neoplasms using coaxial transport system in a day hospital of oncology center].
    Perepelevsky AN; Stanoevich US; Gorivodsky VE
    Khirurgiia (Mosk); 2024; (5):28-35. PubMed ID: 38785236
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The effect of enhanced recovery after lung cancer surgery combined with fine surgical nursing on rehabilitation.
    Dong J; Zhu X
    J Pak Med Assoc; 2024 May; 74(5):874-879. PubMed ID: 38783433
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Prognostic and predictive value of interstitial lung abnormalities and EGFR mutation status in patients with non-small cell lung cancer.
    Xu X; Zhu M; Wang Z; Li J; Ouyang T; Chen C; Huang K; Zhang Y; Gao YL
    Cancer Imaging; 2024 May; 24(1):66. PubMed ID: 38783331
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Exploring the mechanism of 6-Methoxydihydrosanguinarine in the treatment of lung adenocarcinoma based on network pharmacology, molecular docking and experimental investigation.
    Liu X; Ren Y; Qin S; Yang Z
    BMC Complement Med Ther; 2024 May; 24(1):202. PubMed ID: 38783288
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Beyond Chemoimmunotherapy in Advanced Non-Small Cell lung cancer: New Frontiers, New Challenges.
    Mountzios G; Naidoo J; Wang C; Creelan BC; Trotier DC; Campbell TC; Peters S
    Am Soc Clin Oncol Educ Book; 2024 Jun; 44(3):e432526. PubMed ID: 38781566
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Risk factors for pulmonary complications after colorectal cancer surgery: a Japanese multicenter study.
    Tominaga T; Nonaka T; Takamura Y; Oishi K; Hashimoto S; Shiraishi T; Noda K; Ono R; Ishii M; Hisanaga M; Takeshita H; Fukuoka H; Oyama S; Ishimaru K; Kunizaki M; Sawai T; Matsumoto K
    Int J Colorectal Dis; 2024 May; 39(1):76. PubMed ID: 38780615
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Clinical Variables and Radiomics Features for Predicting Pneumothorax in Patients Undergoing CT-guided Transthoracic Core Needle Biopsy.
    Huang YS; Chen JL; Ko WC; Chang YH; Chang CH; Chang YC
    Radiol Cardiothorac Imaging; 2024 Jun; 6(3):e230278. PubMed ID: 38780426
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The association of preoperative hematologic parameters with short-term clinical outcomes in rectal cancer: A feature importance analysis.
    Orafaie A; Shahabi F; Mehri A; Ansari M; Kasraeifar S; Ghiyasi M; Saberi-Karimian M; Abdollahi A; Tabatabaei SM
    Cancer Med; 2024 May; 13(10):e7225. PubMed ID: 38778698
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [The use of medical imaging as a therapeutic patient education tool in radiotherapy : a feasibility study].
    Kirkove D; Ben Mustapha S; Jodogne S; Pétré B
    Rev Med Liege; 2024 May; 79(S1):100-106. PubMed ID: 38778656
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The oral nucleoside prodrug GS-5245 is efficacious against SARS-CoV-2 and other endemic, epidemic, and enzootic coronaviruses.
    Martinez DR; Moreira FR; Catanzaro NJ; Diefenbacher MV; Zweigart MR; Gully KL; De la Cruz G; Brown AJ; Adams LE; Yount B; Baric TJ; Mallory ML; Conrad H; May SR; Dong S; Scobey DT; Nguyen C; Montgomery SA; Perry JK; Babusis D; Barrett KT; Nguyen AH; Nguyen AQ; Kalla R; Bannister R; Feng JY; Cihlar T; Baric RS; Mackman RL; Bilello JP; Schäfer A; Sheahan TP
    Sci Transl Med; 2024 May; 16(748):eadj4504. PubMed ID: 38776389
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. 3,3'-((3,4,5-trifluoropHenyl)methylene)bis(4-hydroxy-2H-chromen-2-one) inhibit lung cancer cell proliferation and migration.
    Luo W; Chang G; Lin D; Xie H; Sun H; Li Z; Mo S; Wang R; Wang Y; Zheng Z
    PLoS One; 2024; 19(5):e0303186. PubMed ID: 38776295
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Blocking the angiopoietin-2-dependent integrin β-1 signaling axis abrogates small cell lung cancer invasion and metastasis.
    Meder L; Orschel CI; Otto CJ; Koker M; Brägelmann J; Ercanoglu MS; Dähling S; Compes A; Selenz C; Nill M; Dietlein F; Florin A; Eich ML; Borchmann S; Odenthal M; Blazquez R; Hilberg F; Klein F; Hallek M; Büttner R; Reinhardt HC; Ullrich RT
    JCI Insight; 2024 May; 9(10):. PubMed ID: 38775153
    [TBL] [Abstract] [Full Text] [Related]  

  • 20.
    McMahon NP; Solanki A; Wang LG; Montaño AR; Jones JA; Samkoe KS; Tichauer KM; Gibbs SL
    Theranostics; 2024; 14(7):2816-2834. PubMed ID: 38773974
    [No Abstract]    [Full Text] [Related]  


    [Next]

    of 5568.